Keywords: elan, gains, european, approval, myocet, corp, received

Elan gains European approval for Myocet

Article | 02 August 2000

Elan Corp has received pan-European approval from the European MedicinesEvaluation Agency for its oncology product Myocet (liposome encapsulated doxorubicin citrate ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Cyclophosphamide

Cytoxan

Go to drug listing